3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
17
NETWORK
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Melanoma
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Central Nervous System Neoplasms
1
Bone Neoplasms
1
Interventions
Oxaliplatin
21
Fluorouracil
20
Leucovorin
19
Capecitabine
18
Irinotecan
13
Radiotherapy
8
Bevacizumab
7
Cetuximab
6
Folfox protocol
4
cediranib
2
Radiation
2
Psychiatric Rehabilitation
2
Octreotide
2
Cisplatin
2
Chemoradiotherapy
2
tipifarnib
1
pertuzumab
1
olaparib
1
mercaptoundecahydrododecaborate
1
eniluracil
1
durvalumab
1
brivanib
1
alpha-Tocopherol
1
Watchful Waiting
1
Vitamin E
1
Trastuzumab
1
Tegafur
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Rectal Neoplasms
×
Surveys and Questionnaires
×
Clear all
NCT04488549
2020-07-28
DECOR-19
Treviso Regional Hospital
Completed
1,051 enrolled